Informations techniques
Exploitant
LUPIN EUROPE GmbH
Présentation
NAMUSCLA 167 mg, gélule
B/30 (CIP : 34009 301 721 2 4)
B/50 (CIP : 34009 301 721 3 1)
B/100 (CIP : 34009 301 721 4 8)
B/200 (CIP : 34009 550 625 8 5)
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
UNp5S868ysCMdMYK
Français